DigestRedComo funciona
Red
/
Empresas
F.
No verificado

F. Hoffmann-La Roche Ltd

Sobre qué escribimos

Anuncios brevesFarmacéuticaPublicidad/Marketing/Medios de comunicación/Comunicación

132 Comunicados de prensa

Ver todos los comunicados de prensa
11/05/2026
Farmacéutica
Anuncios breves
Publicidad/Marketing/Medios de comunicación/Comunicación
Roche receives CE mark for new blood test to detect Alzheimer's pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
06/05/2026
Farmacéutica
Anuncios breves
Publicidad/Marketing/Medios de comunicación/Comunicación
Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
29/04/2026
Farmacéutica
Anuncios breves
Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
22/04/2026
Farmacéutica
Anuncios breves
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
21/04/2026
Farmacéutica
Anuncios breves
Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
21/04/2026
Farmacéutica
Anuncios breves
Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
20/04/2026
Farmacéutica
Anuncios breves
Publicidad/Marketing/Medios de comunicación/Comunicación
FDA accepts application for Roche’s Gazyva/Gazyvaro for the treatment of the most common form of lupus
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
12/04/2026
Farmacéutica
Anuncios breves
Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
29/03/2026
Farmacéutica
Anuncios breves
Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0
23/03/2026
Farmacéutica
Anuncios breves
Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development
Fuente
F. Hoffmann-La Roche Ltd
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0